<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-30780" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Universal Precautions</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Broussard</surname>
            <given-names>Ian M.</given-names>
          </name>
          <aff>Grand Strand Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Kahwaji</surname>
            <given-names>Chadi I.</given-names>
          </name>
          <aff>Universtity of California, Irvine</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Ian Broussard declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Chadi Kahwaji declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>29</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-30780.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Universal precautions were introduced by the Centers for Disease Control (CDC) in 1985, mostly in response to the human immunodeficiency virus (HIV) epidemic. Universal precautions are a standard set of guidelines to prevent the transmission of bloodborne pathogens from exposure to blood and other potentially infectious materials (OPIM). This activity reviews universal precautions and highlights the role of the interprofessional team in their application.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Review the types of universal precautions.</p></list-item><list-item><p>Describe standard precautions.</p></list-item><list-item><p>Summarize airborne precautions.</p></list-item><list-item><p>Outline how an interprofessional team can work together to apply universal precautions to achieve better patient outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=30780&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=30780">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-30780.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Universal precautions were introduced by the Centers for Disease Control (CDC) in 1985, mostly in response to the human immunodeficiency virus (HIV) epidemic.<xref ref-type="bibr" rid="article-30780.r1">[1]</xref><xref ref-type="bibr" rid="article-30780.r2">[2]</xref><xref ref-type="bibr" rid="article-30780.r3">[3]</xref>&#x000a0;Universal precautions are a standard set of guidelines to prevent the transmission of bloodborne pathogens from exposure to blood and other potentially infectious materials (OPIM). OPIM is defined by the Occupational Safety and Health Administration (OSHA) as:</p>
        <list list-type="bullet">
          <list-item>
            <p>The following human body fluids: semen, vaginal secretions, cerebrospinal fluid, synovial fluid, pleural fluid, pericardial fluid, peritoneal fluid, amniotic fluid, saliva in dental procedures, any body fluid that is visibly contaminated with blood, and all body fluids in situations where it is difficult or impossible to differentiate between body fluids;</p>
          </list-item>
          <list-item>
            <p>Any unfixed tissue or organ (other than intact skin) from a human (living or dead); and</p>
          </list-item>
          <list-item>
            <p>HIV-containing cell or tissue cultures, organ cultures, and HIV- or HBV-containing culture medium or other solutions; blood, organs, or other tissues from experimental animals infected with HIV or HBV.</p>
          </list-item>
        </list>
        <p>Universal precautions do not apply to sputum, feces, sweat, vomit, tears, urine, or nasal secretions unless they are visibly contaminated with blood because their transmission of Hepatitis B or HIV is extremely low or nonexistent.</p>
        <p>In 1987, the CDC introduced another set of guidelines termed Body Substance Isolation. These guidelines advocated avoiding direct physical contact with &#x0201c;all moist and potentially infectious body substances,&#x0201d; even if blood is not visible. A limitation of this guideline was that it emphasized handwashing after removing gloves only if the hands were visibly soiled.</p>
        <p>In 1996, the CDC Guideline for Isolation Precautions in Hospitals, prepared by the Healthcare Infection Control Practices Advisory Committee (HICPAC), combined the major features of Universal Precaution and Body Substance Isolation into what is now referred to as Standard Precautions. These guidelines also introduced three transmission-based precautions: airborne, droplet, and contact. All transmission-based precautions are to be used in conjunction with standard precautions.<xref ref-type="bibr" rid="article-30780.r4">[4]</xref><xref ref-type="bibr" rid="article-30780.r5">[5]</xref><xref ref-type="bibr" rid="article-30780.r6">[6]</xref></p>
      </sec>
      <sec id="article-30780.s3" sec-type="Function">
        <title>Function</title>
        <p>
<bold>Standard Precautions</bold>
</p>
        <p>Standard precautions apply to the care of all patients, irrespective of their disease state. These precautions apply when there is a risk of potential exposure to (1) blood; (2) all body fluids, secretions, and excretions,&#x000a0;<italic toggle="yes">except sweat</italic>, regardless of whether or not they contain visible blood; (3) non-intact skin, and (4) mucous membranes.&#x000a0;This includes hand hygiene and personal protective equipment (PPE), with hand hygiene being the single most important means to prevent transmission of disease.<xref ref-type="bibr" rid="article-30780.r7">[7]</xref><xref ref-type="bibr" rid="article-30780.r8">[8]</xref><xref ref-type="bibr" rid="article-30780.r9">[9]</xref><xref ref-type="bibr" rid="article-30780.r10">[10]</xref></p>
        <p>Personal protective equipment&#x000a0;serves as a barrier to protect the skin, mucous membranes, airway, and clothing. It includes gowns, gloves, masks, and face shields or goggles.</p>
        <p>The following list of standard precautions is not all-inclusive and contains some of the most commonly used recommendations for healthcare workers.</p>
        <p>
<bold>Hand Hygiene</bold>
</p>
        <p>Handwashing with soap and water for at least 40 to 60 seconds, making sure not to use clean hands to turn off the faucet, must be performed if hands are visibly soiled, after using the restroom, or if potential exposure to spore-forming organisms.</p>
        <p>Hand rubbing with alcohol applied generously to cover hands completely should be performed, and hands rubbed until dry.</p>
        <p>Hand hygiene indications</p>
        <list list-type="bullet">
          <list-item>
            <p>Before and after any direct patient contact and between patients, whether or not gloves are worn.</p>
          </list-item>
          <list-item>
            <p>Immediately after the gloves are removed.</p>
          </list-item>
          <list-item>
            <p>Before handling an invasive device.</p>
          </list-item>
          <list-item>
            <p>After touching blood, body fluids, secretions, excretions, non-intact skin, and contaminated items, even&#x000a0;when gloves are worn.</p>
          </list-item>
          <list-item>
            <p>During patient care, when moving from a contaminated to a clean body site of the patient.</p>
          </list-item>
          <list-item>
            <p>After contact with inanimate objects in the immediate vicinity of the patient.</p>
          </list-item>
        </list>
        <p>Gloves</p>
        <p>Must be worn when touching blood, body fluids, secretions, excretions, mucous membranes, or non-intact skin. Change when there is contact with potentially infected material in the same patient to avoid cross-contamination. Remove before touching surfaces and clean items. Wearing gloves does not mitigate the need for proper hand hygiene.</p>
        <p>Mask, goggles/eye visor, and/or face shield</p>
        <p>Wear a mask and eye protection or face shield during procedures that may spray or splash blood, body fluids, secretions, or excretions.</p>
        <p>Gown</p>
        <p>Wear to protect skin or clothing during procedures that may spray or splash blood, body fluids, secretions, or excretions.</p>
        <p>Needles and other sharps</p>
        <p>Do not break, bow, or directly manipulate used needles. Recapping is not recommended, but if necessary, &#x0201c;use a one-handed scoop technique only.&#x0201d; Discard all used sharps in appropriate puncture-resistant containers.</p>
        <p>
<bold>Transmission-based Precautions</bold>
</p>
        <p>
<bold>Airborne Precautions</bold>
</p>
        <p>These precautions are used in patients with known or suspected infection with pathogens that are spread by airborne transmission, i.e., &#x0201c;airborne droplet nuclei (small-particle residue {5 um or smaller in size} of evaporated droplets that may remain suspended in the air for long periods of time) or dust particles containing the infectious agent.&#x0201d;</p>
        <p>Patient Placement</p>
        <p>Patients should be placed in a negative pressure isolation room that allows a minimum of 6 to 12 air changes per hour. For patients with active infection with the same pathogen and no other infection,&#x000a0;it is permissible to place patients in the same room together (cohorting). Doors to the room must remain closed at all times. &#x0201c;When a private room is not available, and cohorting is not desirable, consultation with infection control professionals is advised before patient placement.&#x0201d;</p>
        <p>PPE</p>
        <p>Respirators that filter at least 95% of airborne particles must be worn over the nose and mouth, i.e., N95 respirator or powered air-purifying respirator (PAPR) with a high-efficiency particular air (HEPA) filter.</p>
        <p>Transport</p>
        <p>When necessary, patients being transported out of their rooms should wear a surgical mask.</p>
        <p>
<bold>Droplet Precautions</bold>
</p>
        <p>These precautions are used in patients with known or suspected infection with pathogens spread by droplet transmission. &#x0201c;Droplets are particles of respiratory secretions +/- 5 microns. Droplets remain suspended in the air for limited time periods. Transmission is associated with exposure within three to six feet (one to two meters) of the source.&#x0201d;</p>
        <p>Patient Placement</p>
        <p>Private rooms are preferred; however, they may be placed in a semi-private room with another patient having the same active infection and no other infection (cohorting). When a private room or cohorting is not available, the infected patient should be placed at least 3 feet away from other patients and visitors. The doors to the room may be left open, and no special air handling is required.&#x000a0;</p>
        <p>PPE</p>
        <p>Surgical masks should be worn while within 6 feet of the patient.</p>
        <p>Transport</p>
        <p>When necessary, patients being transported out of their rooms should wear a surgical mask.</p>
        <p>
<bold>Contact Precautions</bold>
</p>
        <p>These precautions are used in patients with known or suspected infection or colonization with pathogens spread by direct and indirect patient contact. Indirect patient contact occurs when physical contact is made with items or surfaces in the patient&#x02019;s environment.</p>
        <p>Patient Placement</p>
        <p>Private rooms are preferred; however, they may be placed in a semi-private room with another patient having the same active infection and no other infection (cohorting). &#x0201c;When a private room is not available, and cohorting is not achievable, consider the epidemiology of the microorganism and the patient population when determining patient placement. Consultation with infection control professionals is advised before patient placement.&#x0201d;</p>
        <p>PPE</p>
        <p>Gloves and gowns should be donned before entering the patient's room and removed before leaving. Hand hygiene should be performed immediately afterward. Care should be taken not to touch any potentially contaminated surface upon leaving the room.<xref ref-type="bibr" rid="article-30780.r11">[11]</xref><xref ref-type="bibr" rid="article-30780.r12">[12]</xref></p>
        <p>Transport</p>
        <p>Maintain contact precautions at all times.</p>
        <p>Patient Equipment</p>
        <p>When possible, patients should have dedicated equipment that remains in the room with them, e.g., a single-patient-use blood pressure cuff. If single-patient-use items are not available, they should be cleaned and disinfected before use on another patient.</p>
      </sec>
      <sec id="article-30780.s4" sec-type="Issues of Concern">
        <title>Issues of Concern</title>
        <p>Airborne precautions should be used for the following infections and conditions for the minimum duration listed:</p>
        <list list-type="bullet">
          <list-item>
            <p>Aspergillosis if there is &#x0201c;massive soft tissue infection with copious drainage and repeated irrigations required.&#x0201d;</p>
          </list-item>
          <list-item>
            <p>Herpes zoster that is disseminated or in immunocompromised patients (duration of illness).</p>
          </list-item>
          <list-item>
            <p>Measles (duration of 4 days after onset of rash in an immunocompetent host; duration of illness in immunocompromised).</p>
          </list-item>
          <list-item>
            <p>Monkeypox (duration is until the diagnosis is confirmed and smallpox has been excluded).</p>
          </list-item>
          <list-item>
            <p>Severe acute respiratory syndrome (duration of illness plus 10 days after a fever and respiratory symptoms have resolved or improved).</p>
          </list-item>
          <list-item>
            <p>Smallpox (duration of illness).</p>
          </list-item>
          <list-item>
            <p>Tuberculosis: pulmonary or laryngeal (duration until improving clinically on effective therapy with three negative sputum smears on consecutive days).</p>
          </list-item>
          <list-item>
            <p>Tuberculosis: extrapulmonary, draining lesions (duration until clinically improving and drainage has stopped or consecutively three negative cultures).</p>
          </list-item>
          <list-item>
            <p>Varicella Zoster (duration until the lesions crust and dry).</p>
          </list-item>
        </list>
        <p>Droplet precautions should be used for the following infections and conditions for the duration listed:<xref ref-type="bibr" rid="article-30780.r13">[13]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Adenovirus: pneumonia (duration of illness).</p>
          </list-item>
          <list-item>
            <p>Diphtheria: pharyngeal (duration is until completion and antibiotics and 2 negative cultures 24 hours apart).</p>
          </list-item>
          <list-item>
            <p>Haemophilus influenzae type b: epiglottitis or meningitis (duration is until 24 hours after initiating effective therapy).</p>
          </list-item>
          <list-item>
            <p>Influenza, pandemic</p>
          </list-item>
          <list-item>
            <p>Neisseria meningitidis: meningitis, sepsis, or pneumonia (duration is until 24 hours after initiating effective therapy).</p>
          </list-item>
          <list-item>
            <p>Mumps (duration is 5 days after onset).</p>
          </list-item>
          <list-item>
            <p>Mycoplasma pneumonia (duration of illness).</p>
          </list-item>
          <list-item>
            <p>Parvovirus B19 (duration is 7 days in acute disease, duration of hospitalization in chronic disease of an immunocompromised host).</p>
          </list-item>
          <list-item>
            <p>Pertussis (duration is 5 days).</p>
          </list-item>
          <list-item>
            <p>Yersinia pestis: pneumonic plague (duration is 48 hours).</p>
          </list-item>
          <list-item>
            <p>Group A Streptococcus: pneumonia, pharyngitis, scarlet fever, serious invasive disease (duration is until 24 hours after initiating effective therapy).</p>
          </list-item>
          <list-item>
            <p>Rhinovirus (duration of illness).</p>
          </list-item>
          <list-item>
            <p>Rubella (duration is until 7 days after rash onset).</p>
          </list-item>
          <list-item>
            <p>Severe acute respiratory syndrome (duration of illness plus 10 days after any fever and respiratory symptoms have resolved or improved).</p>
          </list-item>
          <list-item>
            <p>Ebola, Marburg, Crimean-Congo, and Lassa fever viruses: viral hemorrhagic fevers (duration of illness).</p>
          </list-item>
        </list>
        <p>Contact precautions should be used for the following infections and conditions for the duration listed:</p>
        <list list-type="bullet">
          <list-item>
            <p>Abscess, major draining (duration of illness until the cessation of drainage).</p>
          </list-item>
          <list-item>
            <p>Adenovirus: pneumonia (duration of illness).</p>
          </list-item>
          <list-item>
            <p>Burkholderia cepacia in cystic fibrosis patients.</p>
          </list-item>
          <list-item>
            <p>Bronchiolitis (duration of illness).</p>
          </list-item>
          <list-item>
            <p>Clostridium difficile (duration of illness).</p>
          </list-item>
          <list-item>
            <p>Congenital rubella (duration is until 1 year of age, or urine and nasopharyngeal cultures consistently negative after 3 months of age).</p>
          </list-item>
          <list-item>
            <p>Conjunctivitis, viral (duration of illness).</p>
          </list-item>
          <list-item>
            <p>Diphtheria: cutaneous (duration is until completion and antibiotics and 2 negative cultures 24 hours apart).</p>
          </list-item>
          <list-item>
            <p>Staphylococcal furunculosis (duration of illness).</p>
          </list-item>
          <list-item>
            <p>Rotavirus (duration of illness).</p>
          </list-item>
          <list-item>
            <p>Hepatitis A (duration is age-specific in incontinent patients: children less than 3 years old is for the duration of hospitalization; 3&#x000a0;to 14 years old is 2 weeks after onset; greater than 14 years old is 1 week after onset).</p>
          </list-item>
          <list-item>
            <p>Herpes simplex: neonatal, disseminated, severe, or mucocutaneous (duration is until lesions dry and crust).</p>
          </list-item>
          <list-item>
            <p>Herpes zoster: disseminated (duration of illness).</p>
          </list-item>
          <list-item>
            <p>Human metapneumovirus (duration of illness).</p>
          </list-item>
          <list-item>
            <p>Impetigo (duration is until 24 hours after initiating effective therapy).</p>
          </list-item>
          <list-item>
            <p>Lice: head (duration is until 24 hours after initiating effective therapy).</p>
          </list-item>
          <list-item>
            <p>Monkeypox (duration is until lesions crust).</p>
          </list-item>
          <list-item>
            <p>Multidrug-resistant organisms infection or colonization (duration is evidence of ongoing or increased risk of transmission, or while there are wounds that cannot be covered).</p>
          </list-item>
          <list-item>
            <p>Parainfluenza virus (duration of illness).</p>
          </list-item>
          <list-item>
            <p>Poliomyelitis (duration of illness).</p>
          </list-item>
          <list-item>
            <p>Pressure ulcer, major infected (duration of illness).</p>
          </list-item>
          <list-item>
            <p>Respiratory syncytial virus: infants, young children, and immunocompromised adults (duration of illness).</p>
          </list-item>
          <list-item>
            <p>Staphylococcal scalded skin syndrome, Ritter&#x02019;s disease (duration of illness).</p>
          </list-item>
          <list-item>
            <p>Scabies.</p>
          </list-item>
          <list-item>
            <p>Severe acute respiratory syndrome (duration of illness plus 10 days after any fever and respiratory symptoms have resolved or improved).</p>
          </list-item>
          <list-item>
            <p>Smallpox (duration of illness).</p>
          </list-item>
          <list-item>
            <p>Staphylococcus aureus skin infection, major (duration of illness).</p>
          </list-item>
          <list-item>
            <p>Group A streptococcus skin infection, major (duration is until 24 hours after initiating effective therapy).</p>
          </list-item>
          <list-item>
            <p>Tuberculosis: extrapulmonary, draining lesions (duration is until clinically improving and drainage has stopped or three consecutive negative cultures).</p>
          </list-item>
          <list-item>
            <p>Vaccinia (duration is until lesions crust and dry).</p>
          </list-item>
          <list-item>
            <p>Varicella-zoster (duration is until lesions crust and dry).</p>
          </list-item>
          <list-item>
            <p>Ebola, Marburg, Crimean-Congo, and Lassa fever viruses: viral hemorrhagic fevers (duration of illness).</p>
          </list-item>
          <list-item>
            <p>Wound infections, major (duration of illness).</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-30780.s5" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>Occupational exposure to blood and other potentially infectious materials (OPIM) is of such great concern that multiple government agencies have instituted guidelines and regulations regarding universal precautions. Knowledge and implementation of standard precautions are vital to limiting the spread of infectious diseases.<xref ref-type="bibr" rid="article-30780.r14">[14]</xref><xref ref-type="bibr" rid="article-30780.r15">[15]</xref> Their use requires the healthcare provider to be proactive in anticipating the types of exposure they may encounter with each patient, eg, a trauma patient with arterial bleeding would require donning gloves, a mask with a face shield, and a gown. Regarding transmission-based precautions, the healthcare provider should be aware that some diseases require more than one type of transmission-based precautions, eg, disseminated herpes zoster requires contact, airborne, and standard precautions.</p>
      </sec>
      <sec id="article-30780.s6" sec-type="Other Issues">
        <title>Other Issues</title>
        <p>
<bold>Proper Donning and Removal of PPE</bold>
</p>
        <p>Donning of PPE</p>
        <p>The CDC recommends that PPE be donned in the following sequence: (1) gown, (2) mask or respirator, (3) goggles or face shield, and (4) gloves.</p>
        <p>Removal of PPE</p>
        <p>The safe removal of PPE also follows a specific sequence that requires special attention to areas that are now considered contaminated: (1) gloves should be removed by first grasping the palm of the other hand and peeling off the first glove, keeping hold of the removed glove in the gloved hand, slide the fingers of the ungloved hand under the remaining glove and peel it off over the first glove, (2) goggles or face shield should be removed by lifting from behind the head, (3) gowns should be untied and removed by pulling away from the neck and shoulders, turning the gown inside out and only touching the inside, (4) mask or respirator should be removed by reaching behind the head and grasping the bottom ties then the top ties and removed without touching the front. Alternatively, the gloves and gown may be removed at the same time by grasping the gown from the front and pulling away from the body, rolling the gown into a bundle, and removing the gloves at the same time using the inside of the gown. Hand hygiene should be performed after the removal of all PPE and at any time during removal if they become contaminated. If the patient is to be transported outside the room, the healthcare provider should stay in PPE until contact with the patient is over.</p>
      </sec>
      <sec id="article-30780.s7" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>All healthcare workers, including nurse practitioners, are responsible for the prevention of infectious disorders.&#x000a0;In 1996, the CDC Guideline for Isolation Precautions in Hospitals, prepared by the Healthcare Infection Control Practices Advisory Committee (HICPAC), combined the major features of Universal Precaution and Body Substance Isolation into what is now referred to as Standard Precautions. These guidelines also introduced three transmission-based precautions: airborne, droplet, and contact. All transmission-based precautions are to be used in conjunction with standard precautions. Every hospital has an interprofessional team that ensures the proper adoption of the universal guidelines. Audits should randomly be performed, and healthcare workers who do not follow the guidelines should be reprimanded&#x000a0;and sent for remedial education on infection prevention.<xref ref-type="bibr" rid="article-30780.r16">[16]</xref><xref ref-type="bibr" rid="article-30780.r17">[17]</xref></p>
      </sec>
      <sec id="article-30780.s8">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=30780&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=30780">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/30780/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=30780">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-30780.s9">
        <title>References</title>
        <ref id="article-30780.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yasin</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Fisseha</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Mekonnen</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Yirdaw</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Occupational exposure to blood and body fluids and associated factors among health care workers at the University of Gondar Hospital, Northwest Ethiopia.</article-title>
            <source>Environ Health Prev Med</source>
            <year>2019</year>
            <month>Mar</month>
            <day>09</day>
            <volume>24</volume>
            <issue>1</issue>
            <fpage>18</fpage>
            <pub-id pub-id-type="pmid">30851726</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30780.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Larson</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Oronsky</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Varner</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Caroen</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Burbano</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Insel</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Hedjran</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Carter</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Reid</surname>
                <given-names>TR</given-names>
              </name>
            </person-group>
            <article-title>A practical guide to the handling and administration of personalized transcriptionally attenuated oncolytic adenoviruses (PTAVs).</article-title>
            <source>Oncoimmunology</source>
            <year>2018</year>
            <volume>7</volume>
            <issue>9</issue>
            <fpage>e1478648</fpage>
            <pub-id pub-id-type="pmid">30228948</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30780.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brooks</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ballinger</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Nutbeam</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Mander</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Adams</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Nursing and allied health professionals' views about using health literacy screening tools and a universal precautions approach to communication with older adults: a qualitative study.</article-title>
            <source>Disabil Rehabil</source>
            <year>2020</year>
            <month>Jun</month>
            <volume>42</volume>
            <issue>13</issue>
            <fpage>1819</fpage>
            <page-range>1819-1825</page-range>
            <pub-id pub-id-type="pmid">30669896</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30780.r4">
          <label>4</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>King</surname>
                <given-names>KC</given-names>
              </name>
              <name>
                <surname>Strony</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <chapter-title>Needlestick</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>5</month>
            <day>1</day>
            <pub-id pub-id-type="pmid">29630199</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30780.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <collab>Centers for Disease Control and Prevention</collab>
            <article-title>Ebola Virus Disease. Resources and Guidance from the CDC.</article-title>
            <source>Insight</source>
            <year>2015</year>
            <season>Winter</season>
            <volume>40</volume>
            <issue>1</issue>
            <fpage>11</fpage>
            <page-range>11-8</page-range>
            <pub-id pub-id-type="pmid">26364436</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30780.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Goodman</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Griffey</surname>
                <given-names>RT</given-names>
              </name>
              <name>
                <surname>Carpenter</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Blanchard</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kaphingst</surname>
                <given-names>KA</given-names>
              </name>
            </person-group>
            <article-title>Do Subjective Measures Improve the Ability to Identify Limited Health Literacy in a Clinical Setting?</article-title>
            <source>J Am Board Fam Med</source>
            <year>2015</year>
            <season>Sep-Oct</season>
            <volume>28</volume>
            <issue>5</issue>
            <fpage>584</fpage>
            <page-range>584-94</page-range>
            <pub-id pub-id-type="pmid">26355130</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30780.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ndu</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Arinze-Onyia</surname>
                <given-names>SU</given-names>
              </name>
            </person-group>
            <article-title>Standard precaution knowledge and adherence: Do Doctors differ from Medical Laboratory Scientists?</article-title>
            <source>Malawi Med J</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>29</volume>
            <issue>4</issue>
            <fpage>294</fpage>
            <page-range>294-300</page-range>
            <pub-id pub-id-type="pmid">29963283</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30780.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Banach</surname>
                <given-names>DB</given-names>
              </name>
              <name>
                <surname>Bearman</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Barnden</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hanrahan</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Leekha</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Morgan</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Murthy</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Munoz-Price</surname>
                <given-names>LS</given-names>
              </name>
              <name>
                <surname>Sullivan</surname>
                <given-names>KV</given-names>
              </name>
              <name>
                <surname>Popovich</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Wiemken</surname>
                <given-names>TL</given-names>
              </name>
            </person-group>
            <article-title>Duration of Contact Precautions for Acute-Care Settings.</article-title>
            <source>Infect Control Hosp Epidemiol</source>
            <year>2018</year>
            <month>Feb</month>
            <volume>39</volume>
            <issue>2</issue>
            <fpage>127</fpage>
            <page-range>127-144</page-range>
            <pub-id pub-id-type="pmid">29321078</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30780.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <collab>COMMITTEE ON INFECTIOUS DISEASES</collab>
            <article-title>Recommendations for Prevention and Control of Influenza in Children, 2017 - 2018.</article-title>
            <source>Pediatrics</source>
            <year>2017</year>
            <month>Oct</month>
            <volume>140</volume>
            <issue>4</issue>
            <pub-id pub-id-type="pmid">28870977</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30780.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <collab>COMMITTEE ON INFECTIOUS DISEASES</collab>
            <article-title>Recommendations for Prevention and Control of Influenza in Children, 2016-2017.</article-title>
            <source>Pediatrics</source>
            <year>2016</year>
            <month>Oct</month>
            <volume>138</volume>
            <issue>4</issue>
            <pub-id pub-id-type="pmid">27600320</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30780.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <article-title>With strengthened guidelines for health care workers, the CDC ups its game against the deadly Ebola virus.</article-title>
            <source>ED Manag</source>
            <year>2014</year>
            <month>Dec</month>
            <volume>26</volume>
            <issue>12</issue>
            <fpage>133</fpage>
            <page-range>133-6</page-range>
            <pub-id pub-id-type="pmid">25522493</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30780.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hinkin</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Gammon</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Cutter</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Review of personal protection equipment used in practice.</article-title>
            <source>Br J Community Nurs</source>
            <year>2008</year>
            <month>Jan</month>
            <volume>13</volume>
            <issue>1</issue>
            <fpage>14</fpage>
            <page-range>14-9</page-range>
            <pub-id pub-id-type="pmid">18399366</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30780.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moriceau</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Gagneux-Brunon</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gagnaire</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mariat</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Lucht</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Berthelot</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Botelho-Nevers</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Preventing healthcare-associated infections: Residents and attending physicians need better training in advanced isolation precautions.</article-title>
            <source>Med Mal Infect</source>
            <year>2016</year>
            <month>Feb</month>
            <volume>46</volume>
            <issue>1</issue>
            <fpage>14</fpage>
            <page-range>14-9</page-range>
            <pub-id pub-id-type="pmid">26654322</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30780.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Porto</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Marziale</surname>
                <given-names>MH</given-names>
              </name>
            </person-group>
            <article-title>Reasons and consequences of low adherence to standard precautions by the nursing team.</article-title>
            <source>Rev Gaucha Enferm</source>
            <year>2016</year>
            <month>Jun</month>
            <volume>37</volume>
            <issue>2</issue>
            <fpage>e57395</fpage>
            <pub-id pub-id-type="pmid">27253597</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30780.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ritchie</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>McIntyre</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Standardising infection control precautions.</article-title>
            <source>Nurs Times</source>
            <year>2015</year>
            <month>Sep</month>
            <day>16-22</day>
            <volume>111</volume>
            <issue>38</issue>
            <fpage>17</fpage>
            <page-range>17-20</page-range>
            <pub-id pub-id-type="pmid">26513984</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30780.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <article-title>What is the bloodborne pathogens standard?</article-title>
            <source>HDA Now</source>
            <year>2013</year>
            <season>Winter</season>
            <fpage>20</fpage>
            <pub-id pub-id-type="pmid">23556281</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30780.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Peponis</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Cropano</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Larentzakis</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>van der Wilden</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Mejaddam</surname>
                <given-names>YA</given-names>
              </name>
              <name>
                <surname>Sideris</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Michailidou</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Fikry</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Bramos</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Janjua</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>King</surname>
                <given-names>DR</given-names>
              </name>
            </person-group>
            <article-title>Trauma team utilization of universal precautions: if you see something, say something.</article-title>
            <source>Eur J Trauma Emerg Surg</source>
            <year>2017</year>
            <month>Feb</month>
            <volume>43</volume>
            <issue>1</issue>
            <fpage>145</fpage>
            <page-range>145-150</page-range>
            <pub-id pub-id-type="pmid">27084540</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
